Erika P. Hamilton MD, FASCO

Dr. Erika P. Hamilton serves as the director of Breast Cancer Research and executive chair of the Breast Cancer Research Executive Committee for SCRI. In her role as director of Breast Cancer Research, she provides oversight and develops a strategy for the breast program. In Dr. Hamilton’s role as executive chair of the Breast Cancer Research Executive Committee, she builds and manages a comprehensive breast cancer program menu for all sites across the SCRI network.

Dr. Hamilton joined SCRI in 2013 as an investigator in drug development for women’s cancers and has served as director of Breast Cancer Research since 2015. Her mother was diagnosed with breast cancer when Dr. Hamilton was in middle school, and thankfully is a survivor. Dr. Hamilton is passionate about personalized treatment, empowering her patients, and treating each person individually based on their goals and preferences.

Dr. Hamilton received her undergraduate degree from Washington and Lee University in Virginia and received an NCAA Postgraduate Scholarship. She then completed her medical degree and residency from the University of North Carolina at Chapel Hill and fellowship training in hematology and oncology at Duke University. Dr. Hamilton was named to the Women to Watch Class of 2021 for Nashville Medical News. She was selected for the American Society of Clinical Oncology’s (ASCO®) Leadership Development Class for 2021-2022 and was the past chair of ASCO®’s Scientific Committee for Metastatic Breast Cancer for 2019-2020.

She is the current ASCO® Scientific Chair for the 2025 ASCO® Annual Meeting, the 2023-2025 Scientific Committee co-chair of the ESMO Breast Cancer Meeting, was on ASCO®’s plenary committee in 2023, and has served on ASCO®'s Cancer Research Committee since 2024. She was elected to ASCO®'s Nomination Committee in 2024 and will serve a three-year term from 2025-2028. She is also the associate editor for Clinical Breast Cancer. Dr. Hamilton is board-certified in oncology. Additionally, she is a medical oncologist with SCRI Oncology Partners.